A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.
Clinical trial NCT00391092 · COMPLETED
Trial details
- NCT number
- NCT00391092
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2014-08-01
- Enrollment
- 424
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.